期刊文献+

液基细胞学联合免疫细胞化学在痰液脱落细胞诊断非小细胞肺癌中的应用 被引量:20

The non-small cell lung cancer diagnosis by thinprep cytology test and immunocytochemistry in sputum exfoliated cells
下载PDF
导出
摘要 背景与目的:肺癌中非小细胞肺癌(non-small cell lung cancer,NSCLC)发病率最高,NSCLC痰液脱落细胞学诊断已成为肺癌早期诊断的重要辅助手段。本研究旨在探讨液基细胞学和免疫细胞化学方法在NSCLC恶性痰液脱落细胞学标本的分类与诊断中的应用价值。方法:应用液基薄层细胞学自动涂片技术方法筛查到可疑肿瘤细胞及肿瘤细胞的恶性痰液标本共530例进行细胞包埋连续切片,分别作NSCLC肿瘤细胞标志物细胞角蛋白7(cytokeratin-7,CK7)、细胞角蛋白5/6(cytokeratin-5/6,CK5/6)、甲状腺转录因子-1(thyroid transcription factor-1,TTF-1)、P63、上皮膜抗原(epithelial membrane antigen,EMA)免疫细胞化学染色。结果:530例NSCLC恶性痰液患者确诊为肺腺癌265例,鳞癌246例,腺鳞癌19例。TTF-1和CK7在腺癌中有明显高表达,阳性表达率为92.45%(245/265)和91.70%(243/265);CK5/6和P63在鳞癌中有明显高表达,阳性表达率为97.15%(239/246)和99.59%(245/246)。结论:液基细胞学与免疫细胞化学技术相结合在痰液标本诊断中有很重要的临床意义,CK7、CK5/6、TTF-1、P63、EMA联合可用于NSCLC恶性痰液的分类与诊断,值得在临床细胞病理学诊断中推广应用。 Background and purpose: The non-small cell lung cancer (NSCLC) has been the highest disease incidence in lung cancer, spu^rn cytology diagnosis has become an important adjunct to the early diagnosis of lung cancer. The purpose of this study was to investigate the value of thinprep cytological and immunocytochemical method in differentiatial diagnosis ofexfoliated cells of malignant sputum in NSCLC. Methods: Sputum samples were detected with thinprep cytology test, a total of 530 cases suspicious tumor cells and malignant tumor cells sputum specimens were randomly selected in continuous paraffin-embedded sections, respectively, NSCLC tumor cell markers CK7, CK5/6, TTF-1, P63, EMA were evaluted by immunocytochemical staining. Results: Of the 530 cases of malignant sputum, these were confirmed 265 cases of lung adenocarcinoma, 246 cases of squamous carcinoma, 19 cases of adeno-squamous carcinoma. Moreover, TTF-I and CK7 were significantly higher expressed in adenocarcinoma, the positive rates were 92.45% (245/265) and 91.70% (243/265); CK5/6 and P63 were significantly higher expressed in squamous carcinoma, the positive rates were 97.15% (239/246) and 99.59% (245/246). Conclusion: Liquid-based cytology combined with immunocytochemistry had important clinical value in classification and identification of sputum samples, the combination of CK7, CK5/6, TTF-1, P63, EMA can be used for classification and identification of mali^-nant soutum samples between NSCLC. is worthy of nromoting, in clinical cvtoDathology diamaosis.
出处 《中国癌症杂志》 CAS CSCD 北大核心 2014年第3期182-186,共5页 China Oncology
关键词 液基细胞学 免疫细胞化学 痰液 非小细胞肺癌 Thinprep cytological Immunocytochemistry Sputum Non-small cell lung cancer
  • 相关文献

参考文献12

  • 1陈江帆,杜明伟,姜海娇,王秀茹,李建华.免疫细胞化学方法对胸腔积液中恶性肿瘤细胞的分类与诊断[J].中国组织化学与细胞化学杂志,2013,22(1):49-53. 被引量:20
  • 2陈江帆,姜海娇,祝迪,王秀茹,李建华.MOC-31和CD44v6在良恶性腹水鉴别诊断中的应用[J].中国组织化学与细胞化学杂志,2013,22(5):411-415. 被引量:6
  • 3JEMAL A, BRAY F, CENTER M M, et al. Global cancer statistics [ J ] . CA Cancer J Clin, 2011, 61(2): 69-90.
  • 4ERRIDGE S C, MOLLER H, PRICE A, et al. International comparisons of survival from lung cancer: pitfalls and warnings [ J ] . Nat Clin Pract Oncol, 2007, 4(10): 570-577.
  • 5HEES K, LEBEAU P B. Comparison of conventional and ThinPrep preparations of mucoid cytology samples [ J ]. Diagn Cytopathol, 1995, 12(2): 181-185.
  • 6MUKHOPADHYAY S, KATZENSTEIN A L. Subclassification of non-small cell lung carcinomas lacking morphologic differentiation on biopsy specimens: Utility of an immunohistochemical panel containing TTF-1, napsin A, p63, and CK5/6 [ J ] , Am J Surg Pathol, 2011, 5(1): 15-25.
  • 7NG W K, CHOW J C, NG P K. Thyroid transcription factor-1 is highly sensitive and specific in differentiating metastatic pulmonary from extrapulmonary adenocarcinoma in effusion fluid cytology specimens [ J ] . Cancer, 2002, 96(1): 43-48.
  • 8KHAYYATA S, YUN S, PASHA T, et al. Value of p63 and CK5/6 in distinguishing squamous cell carcinoma from adenocarcinoma in lung fine-needle aspiration specimens [ J ]. Dign Cytopathol, 2009, 37(3): 178-183.
  • 9BOKHOVEN H, BRUNNER H G. Splitting p63 [ J ] . Am J Hum Genet, 2002, 71(1):1-13.
  • 10WU M, WANG B, GIL J, et al. P63 and TTF-1 immunostaining. A usefulmarker panel for distinguishing small cell carcinoma of lung from poorly differentiated squamous cell carcinoma of lung [ J ] . Am J Clin Pathol, 2003, 119(5): 696-702.

二级参考文献22

  • 1李建华,付志民,吴广平,韩硕,范玉,周宝森,穆洪.液基细胞学检测对非妇科细胞标本肿瘤细胞诊断的意义[J].中国医科大学学报,2004,33(5):414-415. 被引量:24
  • 2肖宁新,黄耀全,石胜.p63和CK5/6在鳞癌组织中的表达及其鉴别诊断价值[J].中国基层医药,2005,12(4):444-445. 被引量:2
  • 3邬万新,唐正英,张燕萍,钱建育,王振,温晓伟,陆宁.免疫细胞化学鉴别良恶性体腔积液的抗体选择和组合[J].实用肿瘤学杂志,2006,20(5):365-368. 被引量:2
  • 4Monsonego J, Autillo-Touati A, Bergeron C, et al. Liquidbased cytology for primary cervical cancer Screen ing: a multi centre study. British Journa 1 of Cancer, 2001,84(3):360.
  • 5M arelM, Anu stovaM, Stasny B, et al. Incidence of plerual effusion in a well-defined region., epide miologic study in central bohemia. Chest, 1993,104 : 1486-1489.
  • 6Mukhopadhyay S, Katzenstein AL. Subclassification of non-small cell lung carcinomas lacking morphologic differentiation on biopsy specimens Utility of an im- munohistochemical panel containing TTF-1, napsin A, p63 ,and CK5 /6. Am J Surg Pathol,2011,5(1) :15-25.
  • 7Joungho Han, Mi-Kyung Kim, Seok-Jin Nam, et al. E-cadherin and Cytokeratin Subtype Profiling in Effusion Cytology. J Korean Med Sci, 2004,19 : 826-833.
  • 8Sally Hopkins-Donaldson, Larisa. L. Belyanskaya, Ana Paula Simoes-Wust,et al. p53-Induced Apoptosis Occurs in the Absence of p14 (ARF) in Malignant Pleural Mesothelioma. Neoplasia, 2006,8 : 551-559.
  • 9Morgan RL, De Young BR, McGaughy VR, et al. MOC-31 aids in the differentiation between adenocarci- noma and reactive mesothelial cells . Cancer, 1999, 87 (6) :390-394.
  • 10Yanaguch A, Goi T, Yu J, et al. Expression of CD44v6 in advanced gastric cancer and its relationship to hema- togenous metastasis and long-term prognosis. J Surg 0ncol,2002, 79(4) :230-235.

共引文献22

同被引文献172

  • 1吴伟,杨晓坤.GP与MVP方案新辅助化疗治疗非小细胞肺癌的临床疗效[J].求医问药(下半月刊),2012,10(12):606-607. 被引量:4
  • 2刘萌萌.肺穿刺液基细胞学与组织病理学对比研究[J].中国保健营养(上旬刊),2014,25(1):110.
  • 3Khayyata S,Yun S,Pasha T,et al.Value of p63 and CK5/6 in distinguishing squamous cell carcinoma from adenocarcinoma in lung fine-needle aspiration specimens[J].Dign Cytopathol,2009,37(3):178-183.
  • 4Wu GP, Wang EH, Li JH, et al. Clinical application of the liquid-based cytological test in cytological screening of sputum for the diagnosis of lung cancer[J]. Respirology, 2009,22 ( 1 ) : 124-128.
  • 5马正中,阚秀,刘树范.诊断细胞病理学[M].郑州:河南科学技术出版社,2012:235-240.
  • 6宋勇.非小细胞肺癌分期再认识[C].中华医学会第四届全国胸部肿瘤及内窥镜学术会议论文集,2009:31-33.
  • 7刘秋华,林榕波.实体瘤疗效评价标准(RECIST)指南1.1版[C].第十二届全国临床肿瘤大会暨2009年CSCO学术年会论文集,2009:451-451.
  • 8谭勇,吕爱平,查青林,等.肺癌和乳腺癌症状组合与卡氏评分疗效的关系分析[C].2007年中华中医药学会中医药传承创新与发展研讨会论文集,2007:255-257.
  • 9Reynolds JP, Tubbs RR, Minca EC, et al. EGFR mutational gen-otyping of liquid based cytology samples obtained via fine needle aspiration (FNA) at endobronchial ultrasound of non-smal! cell lung cancer (NSCLC) [ J ]. Lung Cancer, 2014,86 (2) : 158 - 163.
  • 10Malapelle U, de Rosa N, Rocco D, et al. EGFR and KRAS muta- tions detection on lung cancer liquid-based cytology: a pilot study [J]. J Clin Pathol,2012,65 ( 1 ) :87 - 91.

引证文献20

二级引证文献90

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部